N Engl J Med[Jour] AND 384 [volume] AND 1[issue]
新英格蘭醫學雜誌 384卷1期
1
Human Molecular Genetics and Genomics-ImportantAdvances and Exciting Possibilities
人類分子遺傳學和基因組學-重要的進展和令人興奮的可能性
Collins, Francis S. M.D., Ph.D.; Doudna,Jennifer A. Ph.D.; et al
New England Journal of Medicine.384(1):1-4,January 7, 2021
2
Lessons We've Learned-Covid-19 and theUndocumented Latinx Community.
我們吸取的經驗教訓-Covid-19和未記錄的Latinx社區
Page, Kathleen R. M.D.; Flores-Miller,Alejandra
New England Journal of Medicine.384(1):5-7,January 7, 2021
3
The Stress of Bayesian Medicine-UncomfortableUncertainty in the Face of Covid-19
貝葉斯醫學的壓力-面對Covid-19的不確定性
Rosenquist, Niels J. M.D., Ph.D.
New England Journal of Medicine.384(1):7-9,January 7, 2021
4
Dipeptidyl Peptidase 4 Inhibition forProphylaxis of Acute Graft-versus-Host Disease
預防急性移植物抗宿主病的二肽基肽酶4抑制作用
Farag, Sherif S. M.D., Ph.D.; AbuZaid, Mohammad M.D.; et al
New England Journal of Medicine.384(1):11-19,January 7, 2021
5
Tocilizumab in Patients Hospitalizedwith Covid-19 Pneumonia
接受Covid-19肺炎住院的患者使用Tocilizumab
Salama, Carlos M.D.; Han, Jian Ph.D.;Yau, Linda Ph.D.; et al
New England Journal of Medicine.384(1):20-30,January 7, 2021
6
Phase 3 Trial of Interleukin-1 TrapRilonacept in Recurrent Pericarditis
復發性心包炎中白細胞介素-1陷阱Rilonacept的3期試驗
Klein, Allan L. M.D.; Imazio, MassimoM.D.; Cremer, Paul M.D.; et al
New England Journal of Medicine.384(1):31-41,January 7, 2021
7
Vaginal Transmission of Cancer fromMothers with Cervical Cancer to Infants
宮頸癌從母親的宮頸向嬰兒的陰道傳播
Arakawa, Ayumu M.D.; Ichikawa, HitoshiPh.D.; Kubo, Takashi Ph.D.; et al
New England Journal of Medicine.384(1):42-50,January 7, 2021
8
Osteoarthritis of the Knee
膝蓋骨關節炎
Sharma, Leena M.D.
New England Journal of Medicine.384(1):51-59,January 7, 2021
9
Open-Book Pelvic Fracture
開放性骨盆骨折
Tai, Ting-Han M.D.; Chen, Chih-YuM.D., Ph.D.
New England Journal of Medicine.384(1):60-60,January 7, 2021
10
Breathing for Two
兩口氣
Rudder, Meghan M.D.; Russo, Melissa M.D.; Ventetuolo, Corey E.M.D.
New England Journal of Medicine.384(1):61-68,January 7, 2021
11
Sitagliptin to Prevent AcuteGraft-versus-Host Disease
西他列汀預防急性移植物抗宿主病
Martin, Paul J. M.D.
New England Journal of Medicine.384(1):70-71,January 7, 2021
12
The Rapid Rise in Cutaneous MelanomaDiagnoses
皮膚黑色素瘤診斷迅速上升
Welch, Gilbert H. M.D., M.P.H.; Mazer,Benjamin L. M.D., M.B.A.; et al
New England Journal of Medicine.384(1):72-79,January 7, 2021
13
Durability of Responses afterSARS-CoV-2 mRNA-1273 Vaccination
SARS-CoV-2mRNA-1273疫苗接種後反應的持久性
Widge, Alicia T. M.D.; Rouphael,Nadine G. M.D. 2; et al
New England Journal of Medicine.384(1):80-82,January 7, 2021
14
Trial of Upadacitinib or Abatacept inRheumatoid Arthritis
類風溼性關節炎的Upadacitinib或Abatacept試驗
Felson, David M.D., M.P.H.; Smolen,Josef S. M.D. 2
New England Journal of Medicine.384(1):83,January 7, 2021
15
Trial of Upadacitinib or Abatacept inRheumatoid Arthritis
類風溼性關節炎的Upadacitinib或Abatacept試驗
Rubbert-Roth, Andrea M.D.; Xavier,Ricardo M. M.D. 2
New England Journal of Medicine.384(1):83-84,January 7, 2021
16
Evolocumab in Pediatric HeterozygousFamilial Hypercholesterolemia
Evolocumab在兒童雜合子家族性高膽固醇血症中的作用
Singh, Aniruddha M.D.; Mittal, ShilpiM.D. 2; Kazimuddin, Mohammed M.D. 3
New England Journal of Medicine.384(1):84,January 7, 2021
17
Evolocumab in Pediatric HeterozygousFamilial Hypercholesterolemia
Evolocumab在兒童雜合子家族性高膽固醇血症中的作用
Gaudet, Daniel M.D., Ph.D.; Ruzza,Andrea M.D., Ph.D. 2; Santos, Raul D. M.D., Ph.D. 3
New England Journal of Medicine.384(1):84-85, January7, 2021
18
Randomized Trial of Nocturnal Oxygenin Chronic Obstructive Pulmonary Disease
慢性阻塞性肺疾病夜間氧氣的隨機試驗
Wu, Jiayuan M.D.;Zhong, Yu M.D.; Lai,TianwenM.D., Ph.D.
New England Journal of Medicine.384(1):85,January 7, 2021
19
Randomized Trial of Nocturnal Oxygenin Chronic Obstructive Pulmonary Disease.
慢性阻塞性肺疾病夜間氧氣的隨機試驗
Lacasse, Yves M.D.; Series, FredericM.D.; Maltais, Francois M.D.
New England Journal of Medicine.384(1):86,January 7, 2021
20
Tocilizumab in Covid-19
Covid-19中的Tocilizumab
Leaf, David E. M.D., M.M.Sc.; Gupta,Shruti M.D., M.P.H.; Wang, Wei Ph.D.
New England Journal of Medicine.384(1):86-87,January 7, 2021
21
Tocilizumab in Covid-19
Covid-19中的Tocilizumab
Stone, John H. M.D., M.P.H.; Horick,Nora K. M.S.; Healy, Brian C. Ph.D.
New England Journal of Medicine.384(1):87, January 7,2021
22
Life Expectancy after BariatricSurgery-the Swedish Obese Subjects Study
減肥手術後的預期壽命-瑞典肥胖受試者研究
Tagliabue, Elena B.Sc. 1; Ceriani,Valerio M.D. 1; Pontiroli, Antonio E. M.D.
New England Journal of Medicine.384(1):88,January 7, 2021
23
Life Expectancy after BariatricSurgery-the Swedish Obese Subjects Study
減肥手術後的預期壽命-瑞典肥胖受試者研究
Gillion, Valentine M.D.; Demoulin,Nathalie M.D.; Devresse, Arnaud M.D.
New England Journal of Medicine.384(1):88,January 7, 2021
24
Life Expectancy after BariatricSurger-the Swedish Obese Subjects Study
減肥手術後的預期壽命-瑞典肥胖受試者研究
Carlsson, Lena M.S. M.D., Ph.D.;Jacobson, Peter M.D., Ph.D. 1; Peltonen, Markku Ph.D. 2
New England Journal of Medicine.384(1):89,January 7, 2021
25
Single or Dual Antiplatelet Treatmentafter TAVI
TAVI後單次或兩次抗血小板治療
Anwar, Sibtain M.D., Ph.D.; Spence,Emily M.D.; Zawadka, Mateusz M.D.
New England Journal of Medicine.384(1):89-90,January 7, 2021
26
Single or Dual Antiplatelet Treatmentafter TAVI
TAVI後單次或兩次抗血小板治療
Eikelboom, Rachel M.D.; Belley-Cote,Emilie P. M.D., Ph.D.; Whitlock, Richard P. M.D., Ph.D.
New England Journal of Medicine.384(1):90,January 7, 2021
27
Single or Dual Antiplatelet Treatmentafter TAVI
TAVI後單次或兩次抗血小板治療
Fahrni, Gregor M.D.; Jeger, Raban M.D.1; Mueller, Christian M.D. 2
New England Journal of Medicine.384(1):90,January 7, 2021.
28
Single or Dual Antiplatelet Treatmentafter TAVI
TAVI後單次或兩次抗血小板治療
Brouwer, Jorn M.D.; Nijenhuis, VincentJ. M.D.; ten Berg, Jurrien M. M.D., Ph.D.
New England Journal of Medicine.384(1):90-91,January 7, 2021
29
Case 26-2020: A Woman with AlteredMental Status and Left-Sided Weakness
案例26-2020：一名精神狀態改變，左手無力的女性
Smith, Colin M. M.D.; Komisar,Jonathan R. M.D.; Niu, Kathy L. M.D.
New England Journal of Medicine.384(1):92,January 7, 2021
30
Case 26-2020: A Woman with AlteredMental Status and Left-Sided Weakness
案例26-2020：一名精神狀態改變，左手無力的女性
Singhal, Aneesh B. M.D., M.B., B.S.; Mukerji,Shibani S. M.D., Ph.D.; Chwalisz, Bart K. M.D.
New England Journal of Medicine.384(1):92,January 7, 2021
31
More on STAT1 Gain of Function, Type 1Diabetes, and JAK Inhibition
有關STAT1功能獲得，1型糖尿病和JAK抑制的更多信息
Johnson, Matthew B. Ph.D.; Hattersley,Andrew T. D.M., F.R.C.P.; et al
New England Journal of Medicine.384(1):93,January 7, 2021
32.
More on STAT1 Gain of Function, Type 1Diabetes, and JAK Inhibition
有關STAT1功能獲得，1型糖尿病和JAK抑制的更多信息
Anderson, Mark S. M.D., Ph.D. 1; Chaimowitz,Natalia S. M.D., Ph.D. 2; Forbes, Lisa R. M.D.
New England Journal of Medicine.384(1):93-94,January 7, 2021.
33.
Visible Intestinal Peristalsis in aNeonate
新生兒可見腸蠕動
Okada, Seigo M.D., Ph.D.; Hasegawa,Shunji M.D., Ph.D.
New England Journal of Medicine.384(1):e1, January 7,2021
N Engl J Med[Jour] AND 384 [volume] AND 2[issue]
新英格蘭醫學雜誌 384卷2期
1
NeutralizingAntibody LY-CoV555 for Outpatient Covid-19.
門診患者Covid-19的中和抗體LY-CoV555。
CasadevallA, Joyner MJ, Pirofski LA.
N EnglJ Med. 2020 Dec 30;384(2):10.1056/NEJMc2033787#sa1.
2
NeutralizingAntibody LY-CoV555 for Outpatient Covid-19. Reply.
門診患者Covid-19的中和抗體LY-CoV555。回復。
NirulaA, Shen L, Skovronsky DM.
N EnglJ Med. 2020 Dec 30;384(2):10.1056/NEJMc2033787#sa2.
N Engl J Med[Jour] AND 384 [volume] AND 3[issue]
新英格蘭醫學雜誌 384卷3期
1
SARS-CoV-2Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
SARS-CoV-2中和抗體LY-CoV555在Covid-19門診患者中的應用。
ChenP, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, Huhn G, Cardona J,Mocherla B, Stosor V, Shawa I, Adams AC, Van Naarden J, Custer KL, Shen L,Durante M, Oakley G, Schade AE, Sabo J, Patel DR, Klekotka P, Skovronsky DM;BLAZE-1 Investigators.
N EnglJ Med. 2021 Jan 21;384(3):229-237.
2
CRISPR-Cas9Gene Editing for Sickle Cell Disease and β-Thalassemia.
鐮狀細胞病和β地中海貧血的CRISPR-Cas9基因編輯。
FrangoulH, Altshuler D, Cappellini MD, Chen YS, Domm J, Eustace BK, Foell J, de laFuente J, Grupp S, Handgretinger R, Ho TW, Kattamis A, Kernytsky A,Lekstrom-Himes J, Li AM, Locatelli F, Mapara MY, de Montalembert M, Rondelli D,Sharma A, Sheth S, Soni S, Steinberg MH, Wall D, Yen A, Corbacioglu S.
N EnglJ Med. 2021 Jan 21;384(3):252-260.
3
REGN-COV2,a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
REGN-COV2，一種中和抗體混合物，用於Covid-19門診患者。
WeinreichDM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Musser BJ, Soo Y, RofailD, Im J, Perry C, Pan C, Hosain R, Mahmood A, Davis JD, Turner KC, Hooper AT,Hamilton JD, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Kohli A, SachdevaY, Graber X, Kowal B, DiCioccio T, Stahl N, Lipsich L, Braunstein N, Herman G,Yancopoulos GD; Trial Investigators.
N EnglJ Med. 2021 Jan 21;384(3):238-251.
4
Polypillwith or without Aspirin in Persons without Cardiovascular Disease.
無心血管疾病患者服用或不服用阿司匹林的Polypill。
YusufS, Joseph P, Dans A, Gao P, Teo K, Xavier D, López-Jaramillo P, Yusoff K,Santoso A, Gamra H, Talukder S, Christou C, Girish P, Yeates K, Xavier F,Dagenais G, Rocha C, McCready T, Tyrwhitt J, Bosch J, Pais P; InternationalPolycap Study 3 Investigators.
N EnglJ Med. 2021 Jan 21;384(3):216-228.
5
Post-TranscriptionalGenetic Silencing of BCL11A to Treat Sickle Cell Disease.
BCL11A轉錄後基因沉默治療鐮狀細胞病。
EsrickEB, Lehmann LE, Biffi A, Achebe M, Brendel C, Ciuculescu MF, Daley H, MacKinnonB, Morris E, Federico A, Abriss D, Boardman K, Khelladi R, Shaw K, Negre H,Negre O, Nikiforow S, Ritz J, Pai SY, London WB, Dansereau C, Heeney MM, ArmantM, Manis JP, Williams DA.
N EnglJ Med. 2021 Jan 21;384(3):205-215.
6
RomanCatholic Diocese of Brooklyn v. Cuomo - The Supreme Court and PandemicControls.
羅馬天主教布魯克林教區訴庫莫-最高法院和流行病控制。
ParmetWE.
N EnglJ Med. 2021 Jan 21;384(3):199-201.
7
PelvicSplenosis.
盆腔脾增生。
WangY, Shen H.
N EnglJ Med. 2021 Jan 21;384(3):e7.
8
PostinfectiousEpigenetic Immune Modifications - A Double-Edged Sword.
感染後的表觀遺傳免疫修飾-一把雙刃劍。
DiNardoAR, Netea MG, Musher DM.
N EnglJ Med. 2021 Jan 21;384(3):261-270.
9
Inductionof Fetal Hemoglobin by Gene Therapy.
通過基因治療誘導胎兒血紅蛋白。
WaltersMC.
N EnglJ Med. 2021 Jan 21;384(3):284-285.
10
AudioInterview: An International Look at Covid-19.
音頻採訪：對Covid-19的國際觀察。
RubinEJ, Baden LR, Nottage K, O'Connell J, Wong G, Morrissey S.
N EnglJ Med. 2021 Jan 21;384(3):e19.
11
AtheroscleroticPlaque Healing.
動脈粥樣硬化斑塊癒合。
WangX, Ge J.
N EnglJ Med. 2021 Jan 21;384(3):293.
12
AtheroscleroticPlaque Healing.
動脈粥樣硬化斑塊癒合。
CorradoD, Thiene G, Basso C.
N EnglJ Med. 2021 Jan 21;384(3):292-293.
13
AtheroscleroticPlaque Healing.
動脈粥樣硬化斑塊癒合。
ChitiA.
N EnglJ Med. 2021 Jan 21;384(3):293-294.
14
MonoclonalAntibodies to Disrupt Progression of Early Covid-19 Infection.
阻斷早期Covid-19感染進展的單克隆抗體。
CohenMS.
N EnglJ Med. 2021 Jan 21;384(3):289-291.
15
Polypills- A Central Strategy for Improving Cardiovascular Health.
息肉病-改善心血管健康的中心策略。
HuffmanMD, Patel A.
N EnglJ Med. 2021 Jan 21;384(3):288-289.
16
Pathergyin Neutrophilic Dermatosis.
中性粒細胞性皮膚病的病理學。
MoonJH, Huynh J.
N EnglJ Med. 2021 Jan 21;384(3):271.
17
AtheroscleroticPlaque Healing. Reply.
動脈粥樣硬化斑塊癒合。回復。
VergalloR, Crea F.
N EnglJ Med. 2021 Jan 21;384(3):294.
18
Treatmentby CRISPR-Cas9 Gene Editing - A Proof of Principle.
CRISPR-Cas9基因編輯治療-原理證明。
MalechHL.
N EnglJ Med. 2021 Jan 21;384(3):286-287.
19
Testingin a Pandemic - Improving Access, Coordination, and Prioritization.
大流行中的檢測——改進獲取、協調和優先順序。
Botti-LodovicoY, Rosenberg E, Sabeti PC.
N EnglJ Med. 2021 Jan 21;384(3):197-199.
20
RenewedThreat of Nuclear Holocaust Requires Physician Activism.
核毀滅的新威脅需要醫生的積極行動。
LownB, Cash RA, Rohde JE.
N EnglJ Med. 2021 Jan 21;384(3):292.
21
Incarcerationand Social Death - Restoring Humanity in the Clinical Encounter.
監禁和社會死亡-恢復人性的臨床遭遇。
SalhiBA, Osborne AD.
N EnglJ Med. 2021 Jan 21;384(3):201-203.
22
Case2-2021: A 26-Year-Old Pregnant Woman with Ventricular Tachycardia and Shock.
病例2-2021：一名26歲孕婦，患有室性心動過速和休克。
ScottNS, Thomas SS, DeFaria Yeh D, Fox AS, Smith RN.
N EnglJ Med. 2021 Jan 21;384(3):272-282.
N Engl J Med[Jour] AND 384 [volume] AND 4[issue]
新英格蘭醫學雜誌 384卷4期
1
CryoballoonAblation as Initial Therapy for Atrial Fibrillation.
冷凍球囊消融術作為房顫的初始治療。
WazniOM, Dandamudi G, Sood N, Hoyt R, Tyler J, Durrani S, Niebauer M, Makati K,Halperin B, Gauri A, Morales G, Shao M, Cerkvenik J, Kaplon RE, Nissen SE; STOPAF First Trial Investigators.
N EnglJ Med. 2021 Jan 28;384(4):316-324.
2
Cryoablationor Drug Therapy for Initial Treatment of Atrial Fibrillation.
心房顫動的冷凍消融或藥物治療。
AndradeJG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, Roux JF, Yung D,Skanes A, Khaykin Y, Morillo C, Jolly U, Novak P, Lockwood E, Amit G, AngaranP, Sapp J, Wardell S, Lauck S, Macle L, Verma A; EARLY-AF Investigators.
N EnglJ Med. 2021 Jan 28;384(4):305-315.
3
InhaledTreprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
吸入曲前列素治療間質性肺疾病所致肺動脈高壓。
WaxmanA, Restrepo-Jaramillo R, Thenappan T, Ravichandran A, Engel P, Bajwa A, AllenR, Feldman J, Argula R, Smith P, Rollins K, Deng C, Peterson L, Bell H, TapsonV, Nathan SD.
N EnglJ Med. 2021 Jan 28;384(4):325-334.
4
Optimismfor Interstitial Lung Disease-Associated Pulmonary Hypertension?
對間質性肺疾病相關肺動脈高壓的樂觀態度？
TaichmanDB.
N EnglJ Med. 2021 Jan 28;384(4):376-377.
5
AtrialFibrillation.
心房顫動。
MichaudGF, Stevenson WG.
N EnglJ Med. 2021 Jan 28;384(4):353-361.
6
Levonorgestrelvs. Copper Intrauterine Devices for Emergency Contraception.
左炔諾孕酮與銅宮內節育器用於緊急避孕的比較。
TurokDK, Gero A, Simmons RG, Kaiser JE, Stoddard GJ, Sexsmith CD, Gawron LM, SandersJN.
N EnglJ Med. 2021 Jan 28;384(4):335-344.
7
Resumptionof Cardiac Activity after Withdrawal of Life-Sustaining Measures.
停止維持生命措施後心臟活動的恢復。
DhananiS, Hornby L, van Beinum A, Scales NB, Hogue M, Baker A, Beed S, Boyd JG,Chandler JA, Chassé M, D'Aragon F, Dezfulian C, Doig CJ, Duska F, Friedrich JO,Gardiner D, Gofton T, Harvey D, Herry C, Isac G, Kramer AH, Kutsogiannis DJ,Maslove DM, Meade M, Mehta S, Munshi L, Norton L, Pagliarello G, Ramsay T,Rusinova K, Scales D, Schmidt M, Seely A, Shahin J, Slessarev M, So D, TalbotH, van Mook WNKA, Waldauf P, Weiss M, Wind JT, Shemie SD; Canadian CriticalCare Trials Group and the Canadian Donation and Transplantation ResearchProgram.
N EnglJ Med. 2021 Jan 28;384(4):345-352.
8
TheSurgeon and the Mother.
外科醫生和母親。
CarmichaelH.
N EnglJ Med. 2021 Jan 28;384(4):302-303.
9
Empagliflozinin Heart Failure.
Empagliflozin治療心力衰竭。
FauchierL, Fauchier G, Angoulvant D.
N EnglJ Med. 2021 Jan 28;384(4):385.
10
Empagliflozinin Heart Failure.
Empagliflozin治療心力衰竭。
ShanmuganathanM, Goswami RM.
N EnglJ Med. 2021 Jan 28;384(4):386.
11
Empagliflozinin Heart Failure.
Empagliflozin治療心力衰竭。
Lin X,Wang S, Huang J.
N EnglJ Med. 2021 Jan 28;384(4):384-385.
12
Dasatinib-Blinatumomabfor Ph-Positive ALL.
DasatinibBlinatumomab用於Ph陽性ALL。
KamachiK, Ureshino H.
N EnglJ Med. 2021 Jan 28;384(4):384.
13
Empagliflozinin Heart Failure.
Empagliflozin治療心力衰竭。
KumarS, Sinha S.
N EnglJ Med. 2021 Jan 28;384(4):387.
14
Empagliflozinin Heart Failure.
Empagliflozin治療心力衰竭。
GérardAO, Favre G, Esnault VLM.
N EnglJ Med. 2021 Jan 28;384(4):386-387.
15
Empagliflozinin Heart Failure.
Empagliflozin治療心力衰竭。
BhattacharyyaD, Kar A.
N EnglJ Med. 2021 Jan 28;384(4):385-386.
16
APulsating Leg.
跳動的腿。
GalMS, Greenberger S.
N EnglJ Med. 2021 Jan 28;384(4):e8.
17
Towarda Medical "Ecology of Attention".
走向醫學「關注生態」。
KisslerMJ, Kissler K, Burden M.
N EnglJ Med. 2021 Jan 28;384(4):299-301.
18
AudioInterview: A Covid-19 Conversation with Anthony Fauci.
音頻採訪：與安東尼·福西的一段Covid-19對話。
RubinEJ, Baden LR, Fauci AS, Morrissey S.
N EnglJ Med. 2021 Jan 28;384(4):e22.
19
EarlyAblation for Paroxysmal Atrial Fibrillation - Safety First.
陣發性心房顫動的早期消融-安全第一。
MarineJE.
N EnglJ Med. 2021 Jan 28;384(4):374-375.
20
Dasatinib-Blinatumomabfor Ph-Positive ALL. Reply.
DasatinibBlinatumomab用於Ph陽性ALL。回復。
Foà R,Chiaretti S.
N EnglJ Med. 2021 Jan 28;384(4):384.
21
Empagliflozinin Heart Failure. Reply.
Empagliflozin治療心力衰竭。回復。
PackerM, Zannad F.
N EnglJ Med. 2021 Jan 28;384(4):387-388.
22
Dapagliflozinin Patients with Chronic Kidney Disease.
達帕格列嗪在慢性腎病患者中的應用。
YasudaH, Isobe S.
N EnglJ Med. 2021 Jan 28;384(4):389.
23
Dapagliflozinin Patients with Chronic Kidney Disease.
達帕格列嗪在慢性腎病患者中的應用。
VogtL.
N EnglJ Med. 2021 Jan 28;384(4):388-389.
24
Effectof CD47 Blockade on Vascular Inflammation.
CD47阻斷對血管炎症的影響。
JarrKU, Nakamoto R, Doan BH, Kojima Y, Weissman IL, Advani RH, Iagaru A, Leeper NJ.
N EnglJ Med. 2021 Jan 28;384(4):382-383.
25
ChangingHand Color after Carpal Tunnel Injection.
腕管注射後手部顏色的改變。
BurkeD.
N EnglJ Med. 2021 Jan 28;384(4):362.
26
AntigenPresentation by B Cells in Multiple Sclerosis.
多發性硬化症中B細胞的抗原呈遞。
ZamvilSS, Hauser SL.
N EnglJ Med. 2021 Jan 28;384(4):378-381.
27
Dapagliflozinin Patients with Chronic Kidney Disease. Reply.
達帕格列嗪在慢性腎病患者中的應用。回復。
HeerspinkHJL, Langkilde AM, Wheeler DC.
N EnglJ Med. 2021 Jan 28;384(4):389-390.
28
Case3-2021: A 48-Year-Old Man with Transient Vision Loss.
病例3-2021：一名48歲男子暫時性視力喪失。
UnizonySH, Kelly HR, O'Donnell EK, Sadigh S.
N EnglJ Med. 2021 Jan 28;384(4):363-372.
29
At theCusp - Reimagining Infective Endocarditis Care amid the Opioid Epidemic.
阿片類藥物流行期間感染性心內膜炎的再成像護理。
InczeMA.
N EnglJ Med. 2021 Jan 28;384(4):297-299.